Dr. PhilippBerrsche

European Counsel

Francfort + 49.69.9726.3955

Contact

Partager

Dr. Philipp Berrsche advises on the structuring and financing of real estate transactions involving share, asset, and forward deals. Philipp focuses his practice on classic asset classes (office, commercial, and residential) as well as on hotel, renewable energies, and logistics. He also advises on contractual issues involving lease, asset management, property management, and heritable building right agreements and on brokerage law and public law compliance issues.

Prior to joining Jones Day, Philipp advised renowned national and international strategic investors and financial investors, including a Chinese fund in connection with the acquisition of a power plant division in Germany and Swiss investors in the acquisition of residential real estate. He also served secondments as a legal advisor to real estate companies and helped prepare one company with its sale and another with securing additional investors.

Expérience

  • Rejuvenate acquires entire business operations of cell transplants manufacturer co.don AktiengesellschaftJones Day advised Rejuvenate GmbH, a subsidiary of ReLive Biotechnologies, in connection with the acquisition of the business operations of co.don Aktiengesellschaft ("CO.DON") (including all shares in its Dutch, UK and Swiss subsidiaries).
  • Ahlström Capital BV and Nidoco AB invest in the Decor business of Ahlstrom-MunksjöJones Day advised Ahlström Capital BV and Nidoco AB in the acquisition of the Decor business of Ahlstrom-Munksjö.
  • MARK Capital sells European portfolio to PrologisJones Day advised MARK Capital in the €1.585 billion sale of Crossbay (by Crossbay SCSp RAIF), its specialized pan-European last-mile logistics platform, to Prologis European Logistics Fund.
  • Plastic Omnium acquires ams OSRAM Automotive Lighting Systems from ams OSRAM GroupJones Day advised Plastic Omnium in the acquisition of the Automotive Lighting Systems (AMLS) business of ams OSRAM Group in a highly complex international carve-out transaction.
  • PTTGC acquires allnex from AdventJones Day advised PTT Global Chemical Public Company Limited in the €4 billion acquisition of allnex Holding GmbH from Advent International.
  • Oxenwood buys German logistics portfolio for €52 millionJones Day advised Oxenwood Real Estate LLP in the acquisition of three logistics facilities in Germany for €52 million.
  • STERIS acquires Cantel Medical for $3.6 billionJones Day advised STERIS plc in its acquisition of Cantel Medical Corp, a global provider of infection prevention products and services primarily to endoscopy and dental customers, for $3.6 billion.
  • SUEZ sells its SUEZ Recycling & Recovery operations to PreZeroJones Day advised the French listed company SUEZ SA in its largest sale of SUEZ Recycling & Recovery operations - excluding plastic recycling and hazardous waste treatment activities - in four continental Europe countries: the Netherlands, Luxembourg, Germany, and Poland to PreZero, the environmental division of Schwarz Group.
  • Atlas Arteria establishes new capital structure for Warnow Tunnel in GermanyJones Day advised Atlas Arteria, a global owner, operator, and developer of toll roads, on a new approximately 29-year debt facility for its Warnow Tunnel in Germany as part of a capital restructuring.
  • STERIS acquires Key Surgical for approximately $850 millionJones Day advised STERIS plc (NYSE: STE) in the $850 million acquisition of Key Surgical, a leading global provider of sterile processing, operating room, and endoscopy products, and a portfolio company of Water Street Healthcare Partners, LLC.
    •

    Avant d’envoyer cet e-mail, veuillez prendre note de ce qui suit :

    Les informations contenues sur le site www.jonesday.com sont destinées à un usage général et ne constituent pas des conseils juridiques. L’envoi et la réception de cet e-mail n’ont pas pour effet de créer une relation avocat-client. Aucun envoi de votre part à un membre du Cabinet ne sera traité comme confidentiel ou protégé à moins que nous n’ayons donné notre accord pour vous représenter. En envoyant cet e-mail, vous confirmez avoir lu et compris la présente notification.